Related references
Note: Only part of the references are listed.Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
Barton F. Haynes et al.
NATURE REVIEWS IMMUNOLOGY (2023)
Efficacy and Safety Profile of Fostemsavir for the Treatment of People with Human Immunodeficiency Virus-1 (HIV-1): Current Evidence and Place in Therapy
Camilla Muccini et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2022)
Temsavir Treatment of HIV-1-Infected Cells Decreases Envelope Glycoprotein Recognition by Broadly Neutralizing Antibodies
Marianne Boutin et al.
MBIO (2022)
Characterization of Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Variants Selected for Resistance to a CD4-Mimetic Compound
Saumya Anang et al.
JOURNAL OF VIROLOGY (2022)
Interleukin-10 contributes to reservoir establishment and persistence in SIV-infected macaques treated with antiretroviral therapy
Justin Harper et al.
JOURNAL OF CLINICAL INVESTIGATION (2022)
Stabilizing the HIV-1 Envelope Glycoprotein State 2A Conformation
Dani Vezina et al.
JOURNAL OF VIROLOGY (2021)
New SHIVs and Improved Design Strategy for Modeling HIV-1 Transmission, Immunopathogenesis, Prevention, and Cure
Hui Li et al.
JOURNAL OF VIROLOGY (2021)
Asymmetric Structures and Conformational Plasticity of the Uncleaved Full-Length Human Immunodeficiency Virus Envelope Glycoprotein Trimer
Shijian Zhang et al.
JOURNAL OF VIROLOGY (2021)
Incomplete immune reconstitution in HIV/AIDS patients on antiretroviral therapy: Challenges of immunological non-responders
Xiaodong Yang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2020)
Long-Acting BMS-378806 Analogues Stabilize the State-1 Conformation of the Human Immunodeficiency Virus Type 1 Envelope Glycoproteins
Shitao Zou et al.
JOURNAL OF VIROLOGY (2020)
The HIV-1 Env gp120 Inner Domain Shapes the Phe43 Cavity and the CD4 Binding Site
Jeremie Prevost et al.
MBIO (2020)
Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection
Michael Kozal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Antigenicity and Immunogenicity of HIV-1 Envelope Trimers Complexed to a Small-Molecule Viral Entry Inhibitor
S. Munir Alam et al.
JOURNAL OF VIROLOGY (2020)
Associating HIV-1 envelope glycoprotein structures with states on the virus observed by smFRET
Maolin Lu et al.
NATURE (2019)
A New Family of Small-Molecule CD4-Mimetic Compounds Contacts Highly Conserved Aspartic Acid 368 of HIV-1 gp120 and Mediates Antibody-Dependent Cellular Cytotoxicity
Shilei Ding et al.
JOURNAL OF VIROLOGY (2019)
Development of an Effective Scalable Enantioselective Synthesis of the HIV-1 Entry Inhibitor BNM-III-170 as the Bis-trifluoroacetate Salt
Junhua Chen et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2019)
Lattice engineering enables definition of molecular features allowing for potent small-molecule inhibition of HIV-1 entry
Yen-Ting Lai et al.
NATURE COMMUNICATIONS (2019)
Inhibitors of HIV-1 Attachment: The Discovery and Development of Temsavir and its Prodrug Fostemsavir
Nicholas A. Meanwell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Beyond the replication-competent HIV reservoir: transcription and translation-competent reservoirs
Amy E. Baxter et al.
RETROVIROLOGY (2018)
Impact of HIV-1 Envelope Conformation on ADCC Responses
Jonathan Richard et al.
TRENDS IN MICROBIOLOGY (2018)
Envelope glycoproteins sampling states 2/3 are susceptible to ADCC by sera from HIV-1-infected individuals
Jeremie Prevost et al.
VIROLOGY (2018)
Uninfected Bystander Cells Impact the Measurement of HIV-Specific Antibody-Dependent Cellular Cytotoxicity Responses
Jonathan Richard et al.
MBIO (2018)
A CD4-mimetic compound enhances vaccine efficacy against stringent immunodeficiency virus challenge
Navid Madani et al.
NATURE COMMUNICATIONS (2018)
Fostemsavir: a new CD4 attachment inhibitor
Pedro Cahn et al.
CURRENT OPINION IN HIV AND AIDS (2018)
HIV-1 Env trimer opens through an asymmetric intermediate in which individual protomers adopt distinct conformations
Xiaochu Ma et al.
ELIFE (2018)
Histidine 375 Modulates CD4 Binding in HIV-1 CRF01_AE Envelope Glycoproteins
Daria Zoubchenok et al.
JOURNAL OF VIROLOGY (2017)
Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches
Matthias Pauthner et al.
IMMUNITY (2017)
Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity Responses
Jeremie Prevost et al.
JOURNAL OF VIROLOGY (2017)
Crystal structures of trimeric HIV envelope with entry inhibitors BMS-378806 and BMS-626529
Marie Pancera et al.
NATURE CHEMICAL BIOLOGY (2017)
HIV-1 gp120 envelope glycoprotein determinants for cytokine burst in human monocytes
Benoit Levast et al.
PLOS ONE (2017)
Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 binding
Daniel W. Kulp et al.
NATURE COMMUNICATIONS (2017)
Unlocking HIV-1 Env: implications for antibody attack
Jonathan Richard et al.
AIDS RESEARCH AND THERAPY (2017)
Development of Broadly Neutralizing Antibodies and Their Mapping by Monomeric gp120 in Human Immunodeficiency Virus Type 1-Infected Humans and Simian-Human Immunodeficiency Virus SHIVSF162P3N-Infected Macaques
Manxue Jia et al.
JOURNAL OF VIROLOGY (2016)
Release of gp120 Restraints Leads to an Entry-Competent Intermediate State of the HIV-1 Envelope Glycoproteins
Alon Herschhorn et al.
MBIO (2016)
Residual inflammation and viral reservoirs: alliance against an HIV cure
Marta Massanella et al.
CURRENT OPINION IN HIV AND AIDS (2016)
Co-receptor Binding Site Antibodies Enable CD4-Mimetics to Expose Conserved Anti-cluster A ADCC Epitopes on HIV-1 Envelope Glycoproteins
Jonathan Richard et al.
EBIOMEDICINE (2016)
Small CD4 Mimetics Prevent HIV-1 Uninfected Bystander CD4+ T Cell Killing Mediated by Antibody-dependent Cell-mediated Cytotoxicity
Jonathan Richard et al.
EBIOMEDICINE (2016)
Pharmacokinetic Interactions between BMS-626529, the Active Moiety of the HIV-1 Attachment Inhibitor Prodrug BMS-663068, and Ritonavir or Ritonavir-Boosted Atazanavir in Healthy Subjects
Li Zhu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
HIV-1 gp120 dimers decrease the overall affinity of gp120 preparations for CD4-induced ligands
Mathieu Coutu et al.
JOURNAL OF VIROLOGICAL METHODS (2015)
CD4 mimetics sensitize HIV-1-infected cells to ADCC
Jonathan Richard et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
The HIV-1 gp120 CD4-Bound Conformation Is Preferentially Targeted by Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies in Sera from HIV-1-Infected Individuals
Maxime Veillette et al.
JOURNAL OF VIROLOGY (2015)
Genotypic correlates of susceptibility to HIV-1 attachment inhibitor BMS-626529, the active agent of the prodrug BMS-663068
Nannan Zhou et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Flow cytometry-based assay to study HIV-1 gp120 specific antibody-dependent cellular cytotoxicity responses
Jonathan Richard et al.
JOURNAL OF VIROLOGICAL METHODS (2014)
Interaction with Cellular CD4 Exposes HIV-1 Envelope Epitopes Targeted by Antibody-Dependent Cell-Mediated Cytotoxicity
Maxime Veillette et al.
JOURNAL OF VIROLOGY (2014)
CD4-Mimetic Small Molecules Sensitize Human Immunodeficiency Virus to Vaccine-Elicited Antibodies
Navid Madani et al.
JOURNAL OF VIROLOGY (2014)
HIV-1 Vpu Antagonism of Tetherin Inhibits Antibody-Dependent Cellular Cytotoxic Responses by Natural Killer Cells
Raymond A. Alvarez et al.
JOURNAL OF VIROLOGY (2014)
A broad HIV-1 inhibitor blocks envelope glycoprotein transitions critical for entry
Alon Herschhorn et al.
NATURE CHEMICAL BIOLOGY (2014)
Slow Turnover of HIV-1 Receptors on Quiescent CD4+ T Cells Causes Prolonged Surface Retention of gp120 Immune Complexes In Vivo
Yasuhiro Suzuki et al.
PLOS ONE (2014)
Tetherin antagonism by Vpu protects HIV-infected cells from antibody-dependent cell-mediated cytotoxicity
Juan F. Arias et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions
James B. Munro et al.
SCIENCE (2014)
In Vitro Antiviral Characteristics of HIV-1 Attachment Inhibitor BMS-626529, the Active Component of the Prodrug BMS-663068
Beata Nowicka-Sans et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
HIV gp120 H375 Is Unique to HIV-1 Subtype CRF01_AE and Confers Strong Resistance to the Entry Inhibitor BMS-599793, a Candidate Microbicide Drug
Susan M. Schader et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Pharmacodynamics, Safety, and Pharmacokinetics of BMS-663068, an Oral HIV-1 Attachment Inhibitor in HIV-1-Infected Subjects
Richard E. Nettles et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
HIV-1 envelope trimer elicits more potent neutralizing antibody responses than monomeric gp120
James M. Kovacs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
In Vivo Patterns of Resistance to the HIV Attachment Inhibitor BMS-488043
Nannan Zhou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
High expression levels of B lymphocyte stimulator (BLyS) by dendritic cells correlate with HIV-related B-cell disease progression in humans
Julie Fontaine et al.
BLOOD (2011)
Immune reconstitution under antiretroviral therapy: the new challenge in HIV-1 infection
Pierre Corbeau et al.
BLOOD (2011)
HIV-1 Envelope Glycoprotein Biosynthesis, Trafficking, and Incorporation
Mary Ann Checkley et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
Receptor-Ligand Requirements for Increased NK Cell Polyfunctional Potential in Slow Progressors Infected with HIV-1 Coexpressing KIR3DL1*h/*y and HLA-B*57
Philomena Kamya et al.
JOURNAL OF VIROLOGY (2011)
Detection of HIV gp120 in Plasma During Early HIV Infection Is Associated with Increased Proinflammatory and Immunoregulatory Cytokines
Jenna Rychert et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2010)
Topological Layers in the HIV-1 gp120 Inner Domain Regulate gp41 Interaction and CD4-Triggered Conformational Transitions
Andres Finzi et al.
MOLECULAR CELL (2010)
The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation
Florencia Pereyra et al.
SCIENCE (2010)
HIV Infection Affects Blood Myeloid Dendritic Cells after Successful Therapy and despite Nonprogressing Clinical Disease
Julie Fontaine et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
HIV-1 Envelope Protein gp120 Is Present at High Concentrations in Secondary Lymphoid Organs of Individuals with Chronic HIV-1 Infection
Michael Santosuosso et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia
Georgia D. Tomaras et al.
JOURNAL OF VIROLOGY (2008)
Is HIV infection a TNF receptor signalling-driven disease?
Georges Herbein et al.
TRENDS IN IMMUNOLOGY (2008)
Functional T cell subsets contribute differentially to HIV peptide-specific responses within infected individuals:: Correlation of these functional T cell subsets with markers of disease progression
Yoav Peretz et al.
CLINICAL IMMUNOLOGY (2007)
Mechanisms of apoptosis induction by the HIV-1 envelope
JL Perfettini et al.
CELL DEATH AND DIFFERENTIATION (2005)
Antigenic conservation and immunogenicity of the HIV coreceptor binding site
JM Decker et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Small-molecule inhibitors of HIV-1 entry block receptor-induced conformational changes in the viral envelope glycoproteins
ZH Si et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Characterization of the outer domain of the gp120 glycoprotein from human immunodeficiency virus type 1
XZ Yang et al.
JOURNAL OF VIROLOGY (2004)
Role of the gp120 inner domain β-sandwich in the interaction between the human immunodeficiency virus envelope glycoprotein subunits
XZ Yang et al.
VIROLOGY (2003)
Mutagenic stabilization and/or disruption of a CD4-bound state reveals distinct conformations of the human immunodeficiency virus type 1 gp120 envelope glycoprotein
SH Xiang et al.
JOURNAL OF VIROLOGY (2002)
Chemokine-receptor activation by env determines the mechanism of death in HIV-infected and uninfected T lymphocytes
SR Vlahakis et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
HIV-1 envelope induces activation of caspase-3 and cleavage of focal adhesion kinase in primary human CD4+ T cells
C Cicala et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
